PlaqueTec wins MedTech Company of the Year at the Cambridge Independent Science and Technology Awards 2024
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), has...
top of page
Latest news
Blogs, news and more...
- May 14
- 2 min
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by...
- Apr 30
- 2 min
PlaqueTec closes $8 million equity financing
The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support...
- Jan 23
- 2 min
PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood
Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary...
- Dec 14, 2023
- 1 min
Profiling plaque to guide treatment of coronary artery disease
Published in Cardiovascular News, Dr Stephen Hoole, Chief Investigator of our BIOPATTERN trial and Consultant Cardiologist at Royal...
- Nov 29, 2023
- 3 min
PlaqueTec recruits first ten patients in BIOPATTERN trial
PlaqueTec receives the UK’s MHRA approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.
- Nov 27, 2023
- 1 min
PlaqueTec presents ePoster at 14th Annual ECS Conference
What is the relationship between protein concentration at site of coronary atheroma and fibrous cap thickness?
bottom of page